A RETROSPECTIVE ANALYSIS OF REPORTED CUTANEOUS ADVERSE DRUG REACTIONS IN A TERTIARY CARE TEACHING HOSPITAL
DOI:
https://doi.org/10.22159/ajpcr.2024.v17i1.48770Keywords:
Keywords: retrospective ADR reports Cutaneous, adverse drug reactions ,tertiary careAbstract
Objectives: Analysis of adverse drug reactions (ADR) reports enriches and updates physician’s awareness about the pattern of cutaneous adverse reactions in the population studied and may play an important role to envision the frequency of appearance of reactions to specific drugs and morphological designs. This study intends to portray the clinical profile and causative agents of dermal ADRs in our population.
Methods: All the ADR reporting forms received from February 2021 to February 2023 were scrutinized, and forms with cutaneous ADRs (CADRs) were analyzed. The data about the history of drug intake, names of the drug taken, time lag of appearance of reaction, and clinical examination details were collected from the reports. Demography, prevalence, reaction time morphological pattern, and causative agents of CADRs were evaluated.
Results: Among the CADRs, acute urticaria 53.4 was the most common followed by acute exanthematous reaction 35.8% and lichenoid drug eruption 3.8%. Among the drugs causing CADRs, antibiotics top the list with 47% followed by ATT at 29.7% and iron sucrose 12.9%. Among the antimicrobials, fluoroquinolones 48% top the list followed by cephalosporins 21.6% and penicillins and vancomycin each 8.3%.
Conclusion: Physician’s knowledge about pattern and causative agents of CADR in the specific population can aid in prevention and early management of ADRs and thereby reducing hospitalization.
Downloads
References
Al-Raaie F, Banodkar DD. Epidemiological study of cutaneous adverse drug reactions in Oman. Oman Med J 2008;23:21-7. PMID 22567204
Mittal N, Gupta M, Singla M. Cutaneous adverse drug reactions notified by pharmacovigilance in a tertiary care hospital in north India. Cutan Ocul Toxicol 2014;33:289-93. doi: 10.3109/15569527.2013.857678, PMID 24517496
Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev 2001;53:357-79.
Murthy AB, Amuthavalli K, Nirmaladevi P, Meenakshi B. Analysis of cutaneous adverse drug reactions in a tertiary care hospital in South Tamil Nadu. Int J Basic Clin Pharmacol 2022;11:97-107. doi: 10.18203/2319-2003.ijbcp20220406
Sharma S, Jayakumar D, Dhanya S. Pharmacovigilance of cutaneous adverse drug reactions among patients attending dermatology department at a tertiary care hospital. Indian Dermatol Online J 2019;10:547-54. doi: 10.4103/idoj.IDOJ_419_18, PMID 31544074
Anant K, Chaukimath SP, Ajit J, Leela H. A study of cutaneous adverse drug reactions; clinical/morphological pattern and causative agents reported in an ADR monitoring centre in a tertiary care hospital of North Karnataka. Biomed Pharmacol J 2020;13:1549-54. doi: 10.13005/ bpj/2029
Jha N, Alexander E, Kanish B, Badyal DK. A study of cutaneous adverse drug reactions in a tertiary care center in Punjab. Indian Dermatol Online J 2018;9:299-303. doi: 10.4103/idoj.IDOJ_81_18, PMID 30258795
Rajendran L, Thyvalappil A, Sridharan R, Ajayakumar S, Sparshadeep E, Divakaran B. A study of cutaneous adverse drug reactions in a tertiary care center in South India. Clin Dermatol Rev 2021;5:173-77. doi: 10.4103/CDR.CDR_109_20
Inbaraj SD, Muniappan M, Muthiah NS, Amutha A, Glory Josephine I, Rahman F. Pharmacovigilance of the cutaneous drug reactions in outpatients of dermatology department at a tertiary care hospital. J Clin Diagn Res 2012;10:1688-91.
Saha A, Das NK, Hazra A, Gharami RC, Chowdhury SN, Datta PK. Cutaneous adverse drug reaction profile in a tertiary care out-patient setting in eastern India. Indian J Pharmacol 2012;44:792-7. doi: 10.4103/0253-7613.103304, PMID 23248414
Sasidharanpillai S, Riyaz N, Rajan U, Binitha MP, Khader A, Mariyath OK, et al. Drug reaction with eosinophilia and systemic symptoms: Observations from a tertiary care institution. Indian J Dermatol Venereol Leprol 2014;80:221-8. doi: 10.4103/0378- 6323.132249, PMID 24823399
Jadhav A, Patil S, Manchanda I, Hasija R, Patil A. Cutaneous adverse drug reactions in a tertiary care teaching hospital: A prospective, observational study. Indian J Dermatol 2021;66:573. doi: 10.4103/ijd. ijd_874_20, PMID 35068528
Patel RM, Marfatia YS. Clinical study of cutaneous drug eruptions in 200 patients. Indian J Dermatol Venereol Leprol 2008;74:430. doi: 10.4103/0378-6323.42883, PMID 18810845
Patel TK, Thakkar SH, Sharma D. Cutaneous adverse drug reactions in Indian population: A systematic review. Indian Dermatol Online J 2014;5(Suppl 2):S76-86. doi: 10.4103/2229-5178.146165, PMID 25593813
Zhao J, Hu L, Zhang L, Maosong Z, Gao L, Cheng L. Causative drugs for drug -induced cutaneous reactions in central China: A 608- case analysis. An Bras Dermatol 2019;94:664-70. doi: 10.1016/j. abd.2019.01.007, PMID 31789251
Published
How to Cite
Issue
Section
Copyright (c) 2023 Pauline Stanislas
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
